ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 133 filers reported holding ADMA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,479,542 | -3.3% | 5,999,872 | -0.3% | 3.17% | +5.2% |
| Q2 2023 | $22,204,841 | +11.5% | 6,017,572 | +0.0% | 3.01% | +11.8% |
| Q1 2023 | $19,909,650 | -14.7% | 6,015,000 | 0.0% | 2.69% | -19.9% |
| Q4 2022 | $23,338,200 | +91.5% | 6,015,000 | +19.9% | 3.36% | +81.6% |
| Q3 2022 | $12,186,000 | +22.7% | 5,015,000 | 0.0% | 1.85% | +18.5% |
| Q2 2022 | $9,930,000 | +16.0% | 5,015,000 | +7.2% | 1.56% | +41.8% |
| Q1 2022 | $8,564,000 | +32.6% | 4,680,000 | +2.2% | 1.10% | +70.2% |
| Q4 2021 | $6,458,000 | – | 4,579,900 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |